Carvedilol (as phosphate ... Available data in pregnant women are insufficient to determine whether there are drug-associated risks of adverse developmental outcomes. There are risks to the ...

[9] Food decreases the absorption of carvedilol, with prolongation of time to peak plasma level but without alteration of the degree of drug absorption. [9] For clinical use, it is recommended ...

Carvedilol was introduced several years ago. This drug has intrinsic anti α-adrenergic activity, resulting in a greater decrease in HVPG than either propranalol or nadolol—and thus appears to ...